| # | Drug | Count |
|---|---|---|
| 0 | PREDNISONE | 14 |
| 1 | CYCLOPHOSPHAMIDE | 12 |
| 2 | CYCLOPHOSPHAMIDE FOR INJECTION | 12 |
| 3 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 12 |
| 4 | DOXORUBICIN | 9 |
| 5 | FUROSEMIDE | 9 |
| 6 | VINORELBINE | 9 |
| 7 | ADALIMUMAB | 8 |
| 8 | ETOPOSIDE | 8 |
| 9 | GEMCITABINE | 8 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | NITAZOXANIDE | 1 | 0.0029 |
| 1 | GAS RELIEF | 1 | 0.0020 |
| 2 | VINORELBINE | 9 | 0.0013 |
| 3 | ERIBULIN MESYLATE | 3 | 0.0008 |
| 4 | IRON DEXTRAN | 1 | 0.0007 |
| 5 | DAUNORUBICIN HYDROCHLORIDE | 1 | 0.0006 |
| 6 | GALANTAMINE HYDROBROMIDE | 1 | 0.0006 |
| 7 | SELUMETINIB | 1 | 0.0006 |
| 8 | ROMIDEPSIN | 1 | 0.0006 |
| 9 | AMIKACIN SULFATE | 1 | 0.0006 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 21 |
| 1 | Alkylating Drug [EPC] | 15 |
| 2 | Benzodiazepine [EPC] | 11 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 11 |
| 4 | Platinum-based Drug [EPC] | 11 |
| 5 | Loop Diuretic [EPC] | 10 |
| 6 | CD20-directed Cytolytic Antibody [EPC] | 9 |
| 7 | Folate Analog Metabolic Inhibitor [EPC] | 8 |
| 8 | Microtubule Inhibitor [EPC] | 8 |
| 9 | Topoisomerase Inhibitor [EPC] | 8 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Histone Deacetylase Inhibitor [EPC] | 1 | 0.0003 |
| 1 | beta Lactamase Inhibitor [EPC] | 1 | 0.0002 |
| 2 | Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] | 1 | 0.0001 |
| 3 | Topoisomerase Inhibitor [EPC] | 8 | 0.0001 |
| 4 | Quinolone Antimicrobial [EPC] | 1 | 0.0001 |
| 5 | Antiprotozoal [EPC] | 1 | 0.0001 |
| 6 | Estrogen Receptor Antagonist [EPC] | 3 | 0.0001 |
| 7 | Parenteral Iron Replacement [EPC] | 1 | 0.0001 |
| 8 | Radioligand Therapeutic Agent [EPC] | 1 | 0.0001 |
| 9 | Nonergot Dopamine Agonist [EPC] | 1 | 0.0001 |